0000950170-24-076867.txt : 20240624
0000950170-24-076867.hdr.sgml : 20240624
20240624170622
ACCESSION NUMBER: 0000950170-24-076867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240624
DATE AS OF CHANGE: 20240624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dadoo Rajeev
CENTRAL INDEX KEY: 0001951685
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 241065203
MAIL ADDRESS:
STREET 1: C/O ARS PHARMACEUTICALS, INC.
STREET 2: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
4
1
ownership.xml
4
X0508
4
2024-06-20
0001671858
ARS Pharmaceuticals, Inc.
SPRY
0001951685
Dadoo Rajeev
985 OLD EAGLE SCHOOL ROAD
SUITE 511
WAYNE
PA
19087
true
false
false
false
false
Stock Option (right to buy)
7.73
2024-06-20
4
A
false
40000
0
A
2034-06-19
Common Stock
40000
40000
D
The shares subject to the option will vest in full on the earlier of June 20, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.
/s/ Sasha Keough, attorney-in-fact for Rajeev Dadoo
2024-06-24